115 related articles for article (PubMed ID: 1374791)
1. Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
Muckenthaler M; Gunkel N; Levantis P; Broadhurst K; Goh B; Colvin B; Forster G; Jackson GG; Oxford JS
J Med Virol; 1992 Feb; 36(2):79-83. PubMed ID: 1374791
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis of reverse transcriptase genes of zidovudine (AZT)-resistant and -sensitive human immunodeficiency virus type 1 strains.
Sheehy N; Desselberger U
J Gen Virol; 1993 Feb; 74 ( Pt 2)():223-8. PubMed ID: 7679140
[TBL] [Abstract][Full Text] [Related]
3. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.
Di Stefano M; Sabri F; Leitner T; Svennerholm B; Hagberg L; Norkrans G; Chiodi F
J Clin Microbiol; 1995 Feb; 33(2):352-5. PubMed ID: 7536214
[TBL] [Abstract][Full Text] [Related]
4. [Mutations of HIV-1 RT gene isolated from patients treated with AZT].
Kondo M; Saito T; Ito A; Oka S; Takata N; Imai M
Kansenshogaku Zasshi; 1993 Mar; 67(3):185-9. PubMed ID: 7683706
[TBL] [Abstract][Full Text] [Related]
5. An in vivo mutation from leucine to tryptophan at position 210 in human immunodeficiency virus type 1 reverse transcriptase contributes to high-level resistance to 3'-azido-3'-deoxythymidine.
Hooker DJ; Tachedjian G; Solomon AE; Gurusinghe AD; Land S; Birch C; Anderson JL; Roy BM; Arnold E; Deacon NJ
J Virol; 1996 Nov; 70(11):8010-8. PubMed ID: 8892925
[TBL] [Abstract][Full Text] [Related]
6. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
7. [Reverse transcriptase gene analysis of HIV-1 mutants cultured in the presence of AZT].
Kondo M; Saito T; Ito A; Oka S; Hamamoto K; Imai M
Kansenshogaku Zasshi; 1993 Oct; 67(10):992-7. PubMed ID: 7504715
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
Iversen AK; Shafer RW; Wehrly K; Winters MA; Mullins JI; Chesebro B; Merigan TC
J Virol; 1996 Feb; 70(2):1086-90. PubMed ID: 8551567
[TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase mutations in sequential HIV-1 isolates in a patient with AIDS.
Gurusinghe AD; Land SA; Birch C; McGavin C; Hooker DJ; Tachedjian G; Doherty R; Deacon NJ
J Med Virol; 1995 Jul; 46(3):238-43. PubMed ID: 7561796
[TBL] [Abstract][Full Text] [Related]
10. Sequence analysis of proviral HIV RT amplified directly by a semi-quantitative technique from AZT treated patients.
Stein CA; Levantis P; Oxford JS
J Med Virol; 1994 Oct; 44(2):115-21. PubMed ID: 7531752
[TBL] [Abstract][Full Text] [Related]
11. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
Nájera I; Richman DD; Olivares I; Rojas JM; Peinado MA; Perucho M; Nájera R; López-Galíndez C
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1479-88. PubMed ID: 7534096
[TBL] [Abstract][Full Text] [Related]
12. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
Larder BA; Kellam P; Kemp SD
Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HIV isolates arising after prolonged zidovudine therapy.
Mayers DL; McCutchan FE; Sanders-Buell EE; Merritt LI; Dilworth S; Fowler AK; Marks CA; Ruiz NM; Richman DD; Roberts CR
J Acquir Immune Defic Syndr (1988); 1992; 5(8):749-59. PubMed ID: 1381438
[TBL] [Abstract][Full Text] [Related]
14. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
[No Abstract] [Full Text] [Related]
15. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
[TBL] [Abstract][Full Text] [Related]
16. Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.
Cases-González CE; Franco S; Martínez MA; Menéndez-Arias L
J Mol Biol; 2007 Jan; 365(2):298-309. PubMed ID: 17070543
[TBL] [Abstract][Full Text] [Related]
17. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
[TBL] [Abstract][Full Text] [Related]
18. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
Gu Z; Gao Q; Li X; Parniak MA; Wainberg MA
J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
[TBL] [Abstract][Full Text] [Related]
19. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.
Kellam P; Boucher CA; Larder BA
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1934-8. PubMed ID: 1371886
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients.
Mohri H; Singh MK; Ching WT; Ho DD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):25-9. PubMed ID: 7678340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
